Scientific publications

Clinical Immunology, 2024
Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease

Alirezaylavasani A., Egner I., Dahl B. et al.

Science of The Total Environment, 2024
Proteomic signatures of ambient air pollution and risk of non-alcoholic fatty liver disease: A prospective cohort study in the UK Biobank

Aimuzi R., Xie Z., Qu Y. et al.

Neuropsychobiology, 2024
Cerebrospinal fluid biomarkers of central nervous system inflammation predict cortical decline in bipolar disorder and ventricular enlargement in healthy controls

Bellaagh Johansson T., Klahn A., Göteson A. et al.

Molecular Therapy, 2024
Dorsal root ganglion toxicity after AAV intra-CSF delivery of a RNAi expression construct into non-human primates and mice

Hawley Z., Pardo I., Cao S. et al.

Signal Transduction and Targeted Therapy, 2024
Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial

Liu J., Wang X., Li Z. et al.

Medicine, 2024
Causal relationships between immune cells, inflammatory cytokines, and pertussis: Bidirectional 2-sample Mendelian randomization study and mediation analysis

Lu F., Feng H., Wang J. et al.

Psoriasis: Targets and Therapy, 2024
Unveiling Novel Protein Biomarkers for Psoriasis Through Integrated Analysis of Human Plasma Proteomics and Mendelian Randomization

Mao R., Zhang T., Yang Z. et al.

Journal of Translational Medicine, 2024
Genomic and clinical characterization of pediatric lymphoepithelioma-like carcinoma

Que Y., Lu X., Lu S. et al.

Cancer Letters, 2024
Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer

Steiner L., Eldh M., Offens A. et al.

Diabetes, Obesity and Metabolism, 2024
Circulating inflammatory proteins are elevated in type 1 and type 2 diabetes and associated to complications

van Heck J., Ajie M., Joosten L. et al.

Journal of Inflammation Research, 2024
A Targeted Proteomics Approach Reveals a Serum Protein Signature as a Diagnostic Biomarker for Colorectal Cancer

Wan Y., Luo W., Song X. et al.

Urolithiasis, 2024
Proteome-wide mendelian randomization identifies therapeutic targets for nephrolithiasis

Wang L., Li K., Chen S. et al.

Diabetes, 2024
Proteomic Signature of Body Mass Index and Risk of Type 2 Diabetes

Wang X., Ma H., Kou M. et al.

Medicine, 2024
Causal relationships between uremic metabolites or toxins and heart failure: Univariate and multivariate Mendelian randomization

Wei M., Hu X., Zhu M. et al.

NeuroImage: Clinical, 2024
State-specific GluCEST alterations in insular subregions are associated with depression and plasma inflammatory biomarker levels in patients with inflammatory bowel disease

Xu L., Lu J., Zhou M. et al.

JACC: Advances, 2024
Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Incident Heart Failure Risk

Yadalam A., Gold M., Patel K. et al.

Advanced Science, 2024
Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention

Youhanna S., Kemas A., Wright S. et al.

Medicine, 2024
Association between immune cell attributes, serum metabolites, inflammatory protein factors, and colorectal cancer: A Mendelian randomization study

Zhang J., Chen H., Yang R. et al.

Molecular Psychiatry, 2024
Large-scale proteomic analyses of incident Alzheimer’s disease reveal new pathophysiological insights and potential therapeutic targets

Zhang Y., Guo Y., He Y. et al.

European Journal of Preventive Cardiology, 2024
Nonobese young females with polycystic ovary syndrome are at high risk for long-term cardiovascular disease

Zhao X., Wang J., Sun D. et al.